New one-a-day pill for bladder cancer to be available on NHS

NHS bladder cancer tablet to be rolled out across England

The drug, recommended by NICE, works by blocking certain proteins to slow down or stop the growth of cancer cells

New one-a-day pill for bladder cancer to be available on NHS

10,000 people are diagnosed with bladder cancer every year

Breakthrough for bladder cancer patients as tablet treatment rolled out on NHS

Hundreds will benefit after the first targeted treatment for the most common form of bladder cancer was given the green light

Unmet Needs in NMIBC

Experts discuss the unmet needs in the treatment of non–muscle-invasive bladder cancer (NMIBC), highlighting areas where advancements are still needed.

Once a day tablet for bladder cancer to be rolled out on NHS - Banbury FM

The first targeted treatment for the most common form of bladder cancer has been given the green light for NHS use. The recommendation on erdafitinib by the National Institute of Health and Care Excellence (Nice) is expected to benefit hundreds of people in England. The drug, also known as Balversa and made by Johnson & Johnson, is taken as a once-a-day tablet and works by blocking certain proteins to slow down or stop the growth of cancer cells…

Once-a-day tablet for bladder cancer to be rolled out on NHS - Rother Radio

The first targeted treatment for the most common form of bladder cancer has been given the green light for NHS use. The recommendation on erdafitinib by the National Institute of Health and Care Excellence (Nice) is expected to benefit hundreds of people in England. The drug, also known as Balversa and made by Johnson & Johnson, is taken as a once-a-day tablet and works by blocking certain proteins to slow down or stop the growth of cancer cells…